Seeking Alpha
 

LipoScience (LPDX)

- NASDAQ
LPDX is defunct.
  • Nov. 12, 2014, 10:02 AM
    • LipoScience (LPDX +0.2%) Q3 results: Revenues: $8.6M (-32.3%); COGS: $2.3M (-11.5%); Operating Expenses: $10.1M (-29.4%); Operating Loss: ($3.8M) (+9.5%); Net Loss: ($4.3M) (+6.5%); Loss Per Share: ($0.28) (+9.7%); Quick Assets: $40M (-20.0%); CF Ops: ($5.4M) (+40%).
    • No guidance given.
    | Nov. 12, 2014, 10:02 AM | Comment!
  • Nov. 12, 2014, 7:32 AM
    • LipoScience (NASDAQ:LPDX): Q3 EPS of -$0.28 misses by $0.02.
    • Revenue of $8.6M (-32.3% Y/Y) misses by $0.2M.
    • Press Release
    | Nov. 12, 2014, 7:32 AM | Comment!
  • Aug. 12, 2014, 5:47 PM
    • LipoScience (LPDX -0.3%) Q2 results: Revenues: $9.0M (-32.1%); Operating Expenses: $10.2M (-19.7%); Net Loss: ($4.1M) (-66.0%); Loss Per Share: ($0.27) (-58.8%); Quick Assets: $42.8M (-13.7%); Cash Burn (1H): ($3.6M) (+47.9%).
    • Q3 Guidance: revenue: $8.5M - 9.0M; volume: 320K - 340K; gross margin: low- to mid-70% range; operating expenses: $10.2M - 10.5M; cash usage: $5M.
    | Aug. 12, 2014, 5:47 PM | Comment!
  • Aug. 12, 2014, 4:19 PM
    • LipoScience (NASDAQ:LPDX): Q2 EPS of -$0.27 misses by $0.03.
    • Revenue of $9M (-32.4% Y/Y) beats by $0.05M.
    • Press Release
    | Aug. 12, 2014, 4:19 PM | Comment!
  • May 12, 2014, 6:03 PM
    • LipoScience (LPDX): Q1 EPS of -$0.13 beats by $0.06.
    • Revenue of $12M (-11.8% Y/Y) misses by $0.03M.
    • Press Release
    | May 12, 2014, 6:03 PM | Comment!
  • Mar. 10, 2014, 5:13 PM
    • LipoScience (LPDX): Q4 EPS of -$0.17 beats by $0.07.
    • Revenue of $12.7M (-6.3% Y/Y) in-line.
    • Press Release
    | Mar. 10, 2014, 5:13 PM | Comment!
  • Aug. 6, 2013, 6:51 AM
    • LipoScience (LPDX): Q2 EPS of -$0.17 beats by $0.01.
    • Revenue of $13.3M misses by $0.25M. (PR)
    | Aug. 6, 2013, 6:51 AM | Comment!
  • May 10, 2013, 6:18 AM
    LipoScience (LPDX): Q1 EPS of -$0.19 misses by $0.01. Revenue of $13.6M misses by $0.55M. (PR)
    | May 10, 2013, 6:18 AM | Comment!
  • Mar. 27, 2013, 4:31 PM
    LipoScience (LPDX): Q4 EPS of $0.13. Revenue of $13.6M (+8.6% Y/Y). (PR)
    | Mar. 27, 2013, 4:31 PM | Comment!
Visit Seeking Alpha's
Company Description
LipoScience Inc is a clinical diagnostic company. The Company focuses on new field of personalized diagnostics based on nuclear magnetic resonance or NMR technology.